UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Neoadjuvant PD-1 Plus Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma

Technology in cancer research & treatment, 2024-01, Vol.23, p.15330338241231610-15330338241231610

2024

Volltextzugriff (PDF)

678 Updated safety and efficacy of toripalimab combined with cetuximab in platinum-refractory recurrent or metastatic head and neck squamous cell carcinoma (R/M-HNSCC): a phase Ib/II clinical trial

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A769-A769

2023

Volltextzugriff (PDF)

Two cycles versus four cycles of neoadjuvant camrelizumab plus chemotherapy in patients with locally advanced esophageal squamous cell carcinoma (ESCC): A prospective, multicenter and randomized study

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.350-350

2023

Volltextzugriff (PDF)

Polymeric micellar paclitaxel plus cisplatin combined with tislelizumab as the first-line treatment of advanced unresectable esophageal squamous cell carcinoma: A phase II study

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.e16022-e16022

2024

Volltextzugriff (PDF)

Association of PIWI-interacting RNA-23210 with tumor metastasis in esophageal squamous cell carcinoma

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e16060-e16060

2023

Volltextzugriff (PDF)

CircATXN7 regulates the proliferation and invasion of esophageal cancer cells through miR-4319/NLRC5

Cellular signalling, 2024-10, Vol.122, p.111341, Article 111341

2024

Volltextzugriff (PDF)

Lung Cancer Risk Associated with Thr495Pro Polymorphism of GHR in Chinese Population

Japanese journal of clinical oncology, 2008-04, Vol.38 (4), p.308-316

2008

Volltextzugriff (PDF)

Safety and efficacy of radiotherapy in combination with immunochemotherapy for advanced esophageal cancer: A retrospective analysis

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.e16032-e16032

2024

Volltextzugriff (PDF)

The Expression and Location of Midkine in Gastric Carcinomas of Chinese Patients

Cellular & molecular immunology, 2007-04, Vol.4 (2), p.135-140

2007

Volltextzugriff (PDF)

Clinical value of piR-36026 and piR-651 in esophageal squamous cell carcinoma

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e15265-e15265

2020

Volltextzugriff (PDF)

Phase-II study of toripalimab combined with neoadjuvant chemotherapy for the treatment of resectable esophageal squamous cell carcinoma

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e16029-e16029

2021

Volltextzugriff (PDF)

SCALE-1: Safety and efficacy of short course neoadjuvant chemo-radiotherapy plus toripalimab for locally advanced resectable squamous cell carcinoma of esophagus

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.4063-4063

2022

Volltextzugriff (PDF)

STAT3/c-Myc Axis-Mediated Metabolism Alternations of Inflammation-Related Glycolysis Involve with Colorectal Carcinogenesis

Rejuvenation research, 2019-04, Vol.22 (2), p.138-145

2019

Volltextzugriff (PDF)

Knockdown of lncRNA TUC338 inhibits esophageal cancer cells migration and invasion

Journal of thoracic disease, 2021-05, Vol.13 (5), p.3061-3069

2021

Volltextzugriff (PDF)

Expression of CircATXN7 in esophageal cancer tissues and its effect on cell proliferation and invasion

Journal of gastrointestinal oncology, 2022-06, Vol.13 (3), p.912-922

2022

Volltextzugriff (PDF)

Polymorphisms of p53 and MDM2 genes are associated with severe toxicities in patients with non-small cell lung cancer

Cancer biology & therapy, 2014-01, Vol.15 (11), p.1542-1551

2014

Volltextzugriff (PDF)

Effects of sintilimab plus chemotherapy as first-line treatment on health-related quality of life in patients with advanced esophageal squamous cell carcinoma: results from the randomized phase 3 ORIENT-15 study

EClinicalMedicine, 2024-06, Vol.72, p.102623-102623, Article 102623

2024

Volltextzugriff (PDF)

Abstract CT075: Updated overall survival outcomes from a randomized, double-blind phase III study of sintilimab versus placebo in combination with chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma (ORIENT-15)

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (8_Supplement), p.CT075-CT075

2023

Volltextzugriff (PDF)

Partial response to chemotherapy in a patient with retroperitoneal inflammatory myofibroblastic tumor

Molecular and clinical oncology, 2016-10, Vol.5 (4), p.463-466

2016

Volltextzugriff (PDF)

Relationship between Polymorphism of Nicotinic Acetylcholine Receptor Gene CHRNA3 and Susceptibility of Lung Cancer

国际转化医学杂志（英文版）, 2013-09 (3), p.107-111

2013

Volltextzugriff (PDF)

Comparison of efficacy and toxicity between gemcitabine plus cisplatin and plus carboplatin in first-line treatment of advanced non-small cell lung cancer

The Chinese-German journal of clinical oncology, 2008-04, Vol.7 (4), p.196-199

2008

Volltextzugriff (PDF)

Closure of the Proto-Tethys Ocean and Early Paleozoic amalgamation of microcontinental blocks in East Asia

Earth-science reviews, 2018-11, Vol.186, p.37-75

2018

Volltextzugriff (PDF)

Chinese Forest Biodiversity Monitoring and Research

Bulletin of the Chinese Academy of Sciences, 2010, Vol.24 (4), p.243-247

MI Xiangcheng DU Yanjun SHEN Guochun HAO Zhanqing YE Wanhui CAO Min MA Keping

2010

Volltextzugriff (PDF)

1 – 25 von 107

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(90)
Mit Volltextzugriff
(90)

Publikationsform

Sprache

Englisch
(106)
Chinesisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Neoadjuvant PD-1 Plus Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma

678 Updated safety and efficacy of toripalimab combined with cetuximab in platinum-refractory recurrent or metastatic head and neck squamous cell carcinoma (R/M-HNSCC): a phase Ib/II clinical trial

Two cycles versus four cycles of neoadjuvant camrelizumab plus chemotherapy in patients with locally advanced esophageal squamous cell carcinoma (ESCC): A prospective, multicenter and randomized study

Polymeric micellar paclitaxel plus cisplatin combined with tislelizumab as the first-line treatment of advanced unresectable esophageal squamous cell carcinoma: A phase II study

Association of PIWI-interacting RNA-23210 with tumor metastasis in esophageal squamous cell carcinoma

CircATXN7 regulates the proliferation and invasion of esophageal cancer cells through miR-4319/NLRC5

Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial

Lung Cancer Risk Associated with Thr495Pro Polymorphism of GHR in Chinese Population

Safety and efficacy of radiotherapy in combination with immunochemotherapy for advanced esophageal cancer: A retrospective analysis

The Expression and Location of Midkine in Gastric Carcinomas of Chinese Patients

Clinical value of piR-36026 and piR-651 in esophageal squamous cell carcinoma

Phase-II study of toripalimab combined with neoadjuvant chemotherapy for the treatment of resectable esophageal squamous cell carcinoma

SCALE-1: Safety and efficacy of short course neoadjuvant chemo-radiotherapy plus toripalimab for locally advanced resectable squamous cell carcinoma of esophagus

STAT3/c-Myc Axis-Mediated Metabolism Alternations of Inflammation-Related Glycolysis Involve with Colorectal Carcinogenesis

Knockdown of lncRNA TUC338 inhibits esophageal cancer cells migration and invasion

Expression of CircATXN7 in esophageal cancer tissues and its effect on cell proliferation and invasion

Polymorphisms of p53 and MDM2 genes are associated with severe toxicities in patients with non-small cell lung cancer

Effects of sintilimab plus chemotherapy as first-line treatment on health-related quality of life in patients with advanced esophageal squamous cell carcinoma: results from the randomized phase 3 ORIENT-15 studyResearch in context

Effects of sintilimab plus chemotherapy as first-line treatment on health-related quality of life in patients with advanced esophageal squamous cell carcinoma: results from the randomized phase 3 ORIENT-15 study

Abstract CT075: Updated overall survival outcomes from a randomized, double-blind phase III study of sintilimab versus placebo in combination with chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma (ORIENT-15)

Partial response to chemotherapy in a patient with retroperitoneal inflammatory myofibroblastic tumor

Relationship between Polymorphism of Nicotinic Acetylcholine Receptor Gene CHRNA3 and Susceptibility of Lung Cancer

Comparison of efficacy and toxicity between gemcitabine plus cisplatin and plus carboplatin in first-line treatment of advanced non-small cell lung cancer

Closure of the Proto-Tethys Ocean and Early Paleozoic amalgamation of microcontinental blocks in East Asia

Chinese Forest Biodiversity Monitoring and Research

Suchergebnisse filtern